Page last updated: 2024-10-26

brl 42810 and Hepatitis, Chronic

brl 42810 has been researched along with Hepatitis, Chronic in 2 studies

Hepatitis, Chronic: INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Man, RA1
Heijtink, RA1
Niesters, HG1
Schalm, SW1
Piqueras, B1
Salcedo, M1
Bañares, R1
García-Durán, F1
Baños, E1
de Diego, A1
Roldán, P1
Cos, E1
Clemente, G1

Reviews

1 review available for brl 42810 and Hepatitis, Chronic

ArticleYear
New developments in antiviral therapy for chronic hepatitis B infection.
    Scandinavian journal of gastroenterology. Supplement, 1995, Volume: 212

    Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Famciclovir; Hepa

1995

Other Studies

1 other study available for brl 42810 and Hepatitis, Chronic

ArticleYear
[Famciclovir plus interferon in the treatment of a patient with chronic hepatitis B and severe liver failure].
    Revista espanola de enfermedades digestivas, 1997, Volume: 89, Issue:3

    Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis, Chr

1997